TABLE OF CONTENTS
Volume 1, Issue 2 (January 2004)
Top of page
Top of page
Top of page
Editorial
Top of pageResearch Articles
Supplying pharmaceuticals to countries without manufacturing capacity: Examining the solution agreed upon by the WTO on 30th August, 2003
Carlos M Correa
J Generic Med 1: 105-119; doi:10.1057/palgrave.jgm.4940002
National and international differences in the prices of branded and unbranded medicines
Giovanni Tafuri, Andrew Creese and Valerio Reggi
J Generic Med 1: 120-127; doi:10.1057/palgrave.jgm.4940003
Promotion, information and advertising: Why increasingly blurred boundaries do not benefit the public
Jackie Glatter
J Generic Med 1: 128-136; doi:10.1057/palgrave.jgm.4940004
Patents, access to medicines and the role of non-governmental organisations
Nathan Ford
J Generic Med 1: 137-145; doi:10.1057/palgrave.jgm.4940005
Secrets of successful patent (non)litigation
Thomas M Saunders and Brian L Michaelis
J Generic Med 1: 146-154; doi:10.1057/palgrave.jgm.4940006
Presages to the coming war over generic biologics
Kurt R Karst
J Generic Med 1: 155-163; doi:10.1057/palgrave.jgm.4940007
Granting emergency interim injunction pending trial in the GSK generic patent litigation: SmithKline Beecham plc and GlaxoSmithKline UK Ltd v Apotex Europe Ltd, Neolab Ltd and Waymade Healthcare plc: [2002] EWHC 2556; [2003] EWCA (Civ) 137
Michael Burdon and Kristie Sloper
J Generic Med 1: 167-175; doi:10.1057/palgrave.jgm.4940008
US Legal and Regulatory Update
Hatch-Waxman research exception has limited application
J Generic Med 1: 177-180; doi:10.1057/palgrave.jgm.4940009
